Design of the REVEAL Registry for US Patients With Pulmonary Arterial Hypertension
- 1 August 2008
- journal article
- research article
- Published by Elsevier BV in Mayo Clinic Proceedings
- Vol. 83 (8), 923-931
- https://doi.org/10.4065/83.8.923
Abstract
No abstract availableKeywords
Funding Information
- United Therapeutics Corporation
- Gilead Sciences
- Actelion Pharmaceuticals
This publication has 11 references indexed in Scilit:
- Registry and Survival Study in Chinese Patients With Idiopathic and Familial Pulmonary Arterial HypertensionSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2007
- The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trialsStatistics in Medicine, 2006
- Temporal trends and drug exposures in pulmonary hypertension: An American experienceAmerican Heart Journal, 2006
- Pulmonary Arterial Hypertension in FranceAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Clinical classification of pulmonary hypertensionJournal of the American College of Cardiology, 2004
- Anorexigens and Pulmonary Hypertension in the United StatesSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2000
- Estimating Causal Effects from Large Data Sets Using Propensity ScoresAnnals of Internal Medicine, 1997
- Nonparametric Estimation and Regression Analysis with Left-Truncated and Right-Censored DataJournal of the American Statistical Association, 1996
- Survival in Patients with Primary Pulmonary HypertensionAnnals of Internal Medicine, 1991
- Primary Pulmonary HypertensionAnnals of Internal Medicine, 1987